Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.

Clin Infect Dis · 2021 · PMC8282326 · PMID 32277809

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In fact, there was a nonsignificant trend toward slightly increased Cryptosporidium shedding in the CFZ group vs the placebo, which was most evident at day 2 of study drug dosing.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.